SNN - Smith+Nephew get FDA clearance for AETOS shoulder implant system
2023-06-12 11:17:28 ET
Medical device maker Smith+Nephew ( NYSE: SNN ) has received market clearance from the US Food and Drug Administration for its AETOS shoulder implant system.
The system is used to help restore range-of-motion and minimize arthritic shoulder pain.
More on Smith+Nephew:
Smith & Nephew stock rises as Q4 revenue grows, sees macro headwinds in FY23
Smith & Nephew reports FY earnings; initiates FY23 guidance
Ambulatory surgery centers, robotics seen as trends for orthopedic devices in 2023
For further details see:
Smith+Nephew get FDA clearance for AETOS shoulder implant system